In the last decade, the field of tissue engineering has emerged as a potential therapeutic strategy for the regeneration and/or repair of various tissues afflicted by cardiovascular disease, such as myocardial infarction (MI) or peripheral artery disease (PAD). Among the different tissue engineering strategies, injectable hydrogels have been extensively studied and show encouraging results in both small and large animal models. An injectable hydrogel provides a favorable microenvironment for endogenous regeneration or repair, and depending on the material's design can be used either alone or as a carrier to deliver therapeutic molecules or stem cells. The type of injectable biomaterial is key for a successful hydrogel-based treatment, and in this chapter, we will focus on acellular injectable biomaterial approaches for both MI and PAD.
Acellular Injectable Biomaterials for Treating Cardiovascular Disease / Gaetani, R.; Ungerleider, J.; Christman, K. L.. - (2015), pp. 309-325. [10.1016/B978-0-12-801888-0.00025-4].
|Titolo:||Acellular Injectable Biomaterials for Treating Cardiovascular Disease|
|Data di pubblicazione:||2015|
|Citazione:||Acellular Injectable Biomaterials for Treating Cardiovascular Disease / Gaetani, R.; Ungerleider, J.; Christman, K. L.. - (2015), pp. 309-325. [10.1016/B978-0-12-801888-0.00025-4].|
|Appartiene alla tipologia:||02a Capitolo o Articolo|